Beckman Coulter Announces First Quarter 20...( Reaffirms Full Year Outlook OR...)

Reaffirms Full Year Outlook

ORANGE COUNTY, Calif., April 28 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer and marketer of products that simplify, automate and innovate complex biomedical testing, announced today first quarter ended March 31, 2009 results. For the first quarter, total revenue was $691.5 million, down 5.3%, or flat in constant currency terms. On a constant currency basis, solid recurring revenue gains of 4.7% were offset by declines in cash instrument sales primarily in Life Science and Cellular Analysis. Reported net earnings were $20.6 million, or $0.32 per fully diluted share, including a $0.03 after-tax, non-cash charge to interest expense due to new accounting rules governing convertible debt instruments. Adjusting for special items (related to restructuring charges and costs of the Olympus acquisition) net earnings were $45.5 million, or $0.71 per fully diluted share, an increase of 9.2% over prior year quarter (See "Non-GAAP Financial Measures.")

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

                                                         Quarter Ended
                                                            March 31
                                                            --------
                                                    2009      2008     % Chg
                                                    ----      ----     -----
    Reported Results (in millions)
    ------------------------------
      Revenue                                      $691.5    $730.5    (5.3%)
      Recurring Revenue                            $573.7    $579.3    (1.0%)
      Operating Income                              $39.6  
'/>"/>
SOURCE  Beckman Coulter, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 
Related biology technology :

1. Beckman Coulter Announces First Quarter 2009 Earnings to be Released on Tuesday, April 28, 2009, After Market Closes
2. Beckman Coulter to Webcast Annual Stockholders Meeting
3. Beckman Coulter to Acquire Lab-Based Diagnostics Business From Olympus Corporation
4. Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals
5. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
6. Beckman Coulter Announces Fourth Quarter 2008 Earnings to be Released on Monday, February 9, 2009, After Market Closes
7. Beckman Coulter to Present at the 27th Annual J.P. Morgan Healthcare Conference
8. Beckman Coulter to Host Annual Business Review
9. Beckman Coulter to Present at Upcoming Healthcare Conferences
10. Beckman Coulter to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
11. Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care